tetano
Editor, Senior Moderator
nnate Immun. 2020 Jan;26(1):26-34. doi: 10.1177/1753425919846281. [h=1]Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease.[/h]
Shirey KA[SUP]1[/SUP], Lai W[SUP]1[/SUP], Brown LJ[SUP]2[/SUP], Blanco JCG[SUP]3[/SUP], Beadenkopf R[SUP]2[/SUP], Wang Y[SUP]2,[/SUP][SUP]4[/SUP], Vogel SN[SUP]1[/SUP], Snyder GA[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] Innate immunity; Toll-like receptor; influenza
PMID: 31955622 DOI: 10.1177/1753425919846281
Shirey KA[SUP]1[/SUP], Lai W[SUP]1[/SUP], Brown LJ[SUP]2[/SUP], Blanco JCG[SUP]3[/SUP], Beadenkopf R[SUP]2[/SUP], Wang Y[SUP]2,[/SUP][SUP]4[/SUP], Vogel SN[SUP]1[/SUP], Snyder GA[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] Innate immunity; Toll-like receptor; influenza
PMID: 31955622 DOI: 10.1177/1753425919846281